Showing results (41-50 of 979) with videos related to
Sort By:
Pageof 98
Current Drug Safety|July 20, 2013
Immunomodulation in inflammatory neuropathies: rationale and safetySaiju Jacob, Yusuf A RajaballyCurrent Drug Safety|January 17, 2013
Vincristine-induced seizure potentiated by itraconazole following RCHOP chemotherapy for diffuse large B-cell lymphomaFarzaneh Foroughinia, Shadi Baniasadi, Sharareh Seifi, et al.Current Drug Safety|January 17, 2013
Isolated unilateral tongue oedema: the adverse effect of Angiotensin converting enzyme inhibitorsEdmund Leung, Marcelino Yazbek Hanna, Nadeem Tehami, et al.Current Drug Safety|February 5, 2013
Deciphering supportive treatment strategies for toxic epidermal necrolysisSerge Jennes, Gerald E Pierard, Philippe PaquetCurrent Drug Safety|February 5, 2013
Long-term benzodiazepine use and mortality: are we doing the right studies?Umesh Kalum Amarasuriya, Puja R Myles, Robert David SandersCurrent Drug Safety|February 28, 2018
Vaping versus Smoking: A Quest for Efficacy and Safety of E-cigaretteHarmeet Singh Rehan, Jahnavi Maini, Amrit Pal Singh HunginCurrent Drug Safety|February 28, 2018
Risks Associated with SGLT2 Inhibitors: An OverviewMahakpreet Singh, Anoop KumarCurrent Drug Safety|February 27, 2016
Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma ConcentrationsGuillermo A Keller, María C V Etchegoyen, Nicolás Fernandez, et al.Current Drug Safety|February 27, 2016
Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort StudyJohn V Peter, Greeshma H Varghese, Hanna Alexander, et al.Current Drug Safety|October 30, 2019
Mycophenolate Mofetil-induced Oral Ulcerations in a Kidney Transplant RecipientHanène Gaied, Mohamed Mongi Bacha, Tasnim Mesbahi, et al.Pageof 98